The short version of gastric juice protein fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-03. Anything still debated is marked as such rather than presented as settled.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
| Property | Value | Notes |
|---|---|---|
| Molar mass | Approximately 1419.5 g/mol | Calculated from the reported 15-residue sequence |
| Molecular formula | C62H98N16O22 | Based on the same sequence |
| Appearance | White to off-white powder | Typical of a lyophilized preparation |
| Solubility class | Freely soluble in water | Also dissolves in saline solutions |
| Typical storage temperature | Minus 20 degrees Celsius, dry | Refrigeration advised after reconstitution |
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
Hydrophobic membranes are often polydimethylsiloxane based where the actual separation mechanism is based on the solution-diffusion model described above. Hydrophilic membranes are more widely available. The commercially most successful pervaporation membrane system to date is based on polyvinyl alcohol. More recently also membranes based on polyimide have become available. To overcome the intrinsic disadvantages of polymeric membrane systems ceramic membranes have been developed over the last decade. These ceramic membranes consist of nanoporous layers on top of a macroporous support. The pores must be large enough to let water molecules pass through and retain any other solvents that have a larger molecular size such as ethanol. As a result, a molecular sieve with a pore size of about 4 Å is obtained. The most widely available member of this class of membranes is that based on zeolite A. Alternatively to these crystalline materials, the porous structure of amorphous silica layers can be tailored towards molecular selectivity. These membranes are fabricated by sol-gel chemical processes. Research into novel hydrophilic ceramic membranes has been focused on titania or zirconia. Very recently a break-through in hydrothermal stability has been achieved through the development of an organic-inorganic hybrid material.
=== Seizures === Midazolam is sometimes used for the acute management of prolonged seizures. Long-term use for the management of epilepsy is not recommended due to the significant risk of tolerance (which makes midazolam and other benzodiazepines ineffective) and the significant side effect of sedation. A benefit of midazolam is that in children it can be given in the cheek or in the nose for acute seizures, including status epilepticus. Drawbacks include a high degree of breakthrough seizures—due to the short half-life of midazolam—in over 50% of people treated, as well as treatment failure in 14–18% of people with refractory status epilepticus. Tolerance develops rapidly to the anticonvulsant effect, and the dose may need to be increased by several times to maintain anticonvulsant therapeutic effects. With prolonged use, tolerance and tachyphylaxis can occur and the elimination half-life may increase, up to days. Buccal and intranasal midazolam may be both easier to administer and more effective than rectally administered diazepam in the emergency control of seizures.
Detection of substituted phenethylamines, which include compounds such as 2C-B, MDMA, and other designer drugs, involves various analytical methods aimed at identifying these psychoactive substances. These compounds are structurally similar to amphetamines, making their detection challenging due to potential cross-reactivity in standard drug tests. Techniques like gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), and immunoassay screenings are commonly employed for accurate identification. Advanced methods like high-performance liquid chromatography (HPLC) allow for precise separation and quantification of these substances even at low concentrations. Given the rising use of these drugs in recreational settings, developing sensitive and specific detection techniques remains crucial in forensic toxicology and clinical diagnostics.
From 1930, white women had the vote, and the right to serve as senators and MPs, on the same basis as white men. In 1934, Parliament was declared "the sovereign legislative power in and over the Union". From 1937, black voters were separated from the other races – in the Senate they were represented by four elected senators (two for the Cape, one for Natal, one for the Orange Free State and Transvaal), and in the House of Assembly by three "native representative" MPs elected in separate black constituencies. From 1950, white voters in South West Africa, which was under South African administration at that time, were represented by four senators and six MPs. From 1957, Coloured voters were separated from the whites – in the Senate, they were represented by separate senators, and in the House of Assembly by MPs elected in separate Coloured constituencies. To pass this amendment in the face of strong opposition (and two Supreme Court rulings), prime minister Johannes Strijdom had to enlarge the Senate and appoint enough pro-government senators to get the two-thirds majority he needed to force through the constitutional change. Representation of black voters was ended in 1960. Voting age was lowered from 21 to 18 in 1960. In a referendum held in 1960, a small majority of white voters approved the conversion of the country from a constitutional monarchy to a parliamentary republic.
Sources: en.wikipedia.org
== Nomenclature == Confusingly, there are two "standard" nomenclatures for FPR receptors and their genes, the first used, FPR, FPR1, and FPR2 and its replacement, FPR1, FPR2 (this gene), and FPR3. The latter nomenclature is recommended by the International Union of Basic and Clinical Pharmacology and is used here. Other previously used names for FPR1 are NFPR, and FMLPR; for FPR2 are FPRH1, FPRL1, RFP, LXA4R, ALXR, FPR2/ALX, HM63, FMLPX, and FPR2A; and for FPR3 are FPRH2, FPRL2, and FMLPY.
677TT (but not 677CC/CT) individuals with lower plasma folate levels are at risk for elevated plasma homocysteine levels. In studies of human recombinant MTHFR, the protein encoded by 677T loses its FAD cofactor three times faster than the wild-type protein. 5-Methyl-THF slows the rate of FAD release in both the wild-type and mutant enzymes, although it is to a much greater extent in the mutant enzyme. Low folate status with the consequent loss of FAD enhances the thermolability of the enzyme, thus providing an explanation for the normalised homocysteine and DNA methylation levels in folate-replete 677TT individuals. This polymorphism and mild hyperhomocysteinemia are associated with neural tube defects in offspring, increased risk for complications of pregnancy other complications of pregnancy, arterial and venous thrombosis, and cardiovascular disease. 677TT individuals are at an increased risk for acute lymphoblastic leukemia and colon cancer. Mutations in the MTHFR gene could be one of the factors leading to increased risk of developing schizophrenia. Schizophrenic patients having the risk allele (T\T) show more deficiencies in executive function tasks. The C677T genotype used to be associated with increased risk of recurrent pregnancy loss (RPL) in non Caucasians, however this link has been disproved in recent years. The American College of Medical Genetics recommendation guidelines currently state that people with recurrent pregnancy loss should not be tested for variants in the MTHFR gene. There is also a tentative link between MTHFR mutations and dementia.
== Implications == The Father Tongue hypothesis has far-reaching implications for several processes in linguistics such as language change, language acquisition and sociolinguistics. The Father Tongue hypothesis also has implications for language acquisition, as the hypothesis suggests an evolutionary explanation for why females may be better in some aspects of language performance and acquisition. Van Driem interpreted the correlation of Y-chromosomal haplogroups and language families as indicating that the spread of language families was often mediated by male-biased migration, whether these intrusions were martial or something less spectacular. He conjectured that the majority of language communities spoke father tongues rather than mother tongues. The Father Tongue hypothesis has implications for linguists' understanding of language change. It must be assumed that the dynamics of language change whereby mothers pass on the language of their spouses to their offspring differ from the dynamics of language change in a monolingual community and even from the dynamics of change in a bilingual community where mothers pass on their own language to their children. As a consequence, such dynamics can introduce a discontinuity with the past. For example, it has been observed that Michif, genetically an Algonquian language (like Plains Cree), was relexified by Métis women with Métis French, the language of their husbands, and so the genetic affinity of Michif has come to be almost unidentifiable.
Sources: en.wikipedia.org
=== The Deep Hot Biosphere === At the beginning of his 1992 paper The Deep Hot Biosphere, Thomas Gold referred to ocean vents in support of his theory that the lower levels of the earth are rich in living biological material that finds its way to the surface. He further expanded his ideas in the book The Deep Hot Biosphere. An article on abiogenic hydrocarbon production in the February 2008 issue of Science journal used data from experiments at the Lost City hydrothermal field to report how the abiotic synthesis of low molecular mass hydrocarbons from mantle derived carbon dioxide may occur in the presence of ultramafic rocks, water, and moderate amounts of heat.
Charlotte, with intermediate stops including Cary, Durham, Burlington and Greensboro, North Carolina. New York City, with intermediate stops including Richmond, VA; Washington, D.C.; Baltimore, MD; and Philadelphia, PA. Miami, with intermediate stops including Columbia, SC, and Savannah, GA; as well as Jacksonville, Orlando and Tampa, FL. Chicago, with intermediate stops including Pittsburgh, PA, Cleveland, OH, and Toledo, OH.
Psilocybin, a naturally occurring chemical in certain psychedelic mushrooms such as Psilocybe cubensis, is being studied for its ability to help people suffering from psychological disorders, such as obsessive–compulsive disorder. Minute amounts have been reported to stop cluster and migraine headaches. A double-blind study, done by Johns Hopkins Hospital, showed psychedelic mushrooms could provide people an experience with substantial personal meaning and spiritual significance. In the study, one third of the subjects reported ingestion of psychedelic mushrooms was the single most spiritually significant event of their lives. Over two-thirds reported it among their five most meaningful and spiritually significant events. On the other hand, one-third of the subjects reported extreme anxiety. However the anxiety went away after a short period of time. Psilocybin mushrooms have also shown to be successful in treating addiction, specifically with alcohol and cigarettes. A few species in the genus Amanita, most recognizably A. muscaria, but also A. pantherina, among others, contain the psychoactive compound muscimol. The muscimol-containing chemotaxonomic group of Amanitas contains no amatoxins or phallotoxins, and as such are not hepatoxic, though if not properly cured will be non-lethally neurotoxic due to the presence of ibotenic acid. The Amanita intoxication is similar to Z-drugs in that it includes CNS depressant and sedative-hypnotic effects, but also dissociation and delirium in high doses.
== Ecological status == In 1998, the International Union for Conservation of Nature warned that one of the primary frankincense species, Boswellia sacra, is "near threatened". Frankincense trees are not covered by the Convention on International Trade in Endangered Species of Wild Fauna and Flora, but experts argue that Boswellia species meet the criteria for protection. In a 2006 study, an ecologist at Wageningen University & Research claimed that, by the late-1990s, Boswellia papyrifera trees in Eritrea were becoming hard to find. In 2019, a new paper predicted a 50% reduction in Boswellia papyrifera within the next two decades. This species, found mainly in Ethiopia, Eritrea, and Sudan, accounts for about two-thirds of global frankincense production. The paper warns that all Boswellia species are threatened by habitat loss and overexploitation. Most Boswellia grow in harsh, arid regions beset by poverty and conflict. Harvesting and selling the tree's resin is one of the few sources of income for the inhabitants, resulting in overtapping.
Sources: en.wikipedia.org
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.
It marks the position of the sequence inside the original protein. The label traces back to early work fractionating gastric juice and describing a body protection compound. The figure does not refer to molecular weight or to the count of amino acids.
No. The sequence has no cysteine residues, so disulfide bridges cannot form. That feature makes it easier to handle than many small proteins that depend on multiple cysteines for structure.
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.